Costimulatory bispecific antibodies revolutionize multiple myeloma treatment, offering deeper responses and flexible sequencing strategies for patients.
Karen Rodriguez-Lorenc, MD
Advertisement
Articles by Karen Rodriguez-Lorenc, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
FDA Alleges Association Between Prenatal Acetaminophen Use and Autism in Children
2
Belatamab Mafodotin Triplet Improved Survival, Responses in Patients Refractory to Lenalidomide
3
FDA Grants Accelerated Approval to Elamipretide, First Treatment for Barth Syndrome
4
IMS 2025: Improving Patient Experience with On-Body Injector Administration of Isatuximab-Irfc
5
